PharmD Info

A forum for Indian Pharmacy Professionals

Pharmacotherapy Cases, Problem Based, and Case-Based Learning, Simulated Case Studies, Clinical Pharmacy Cases, PharmD Practical Case Studies.
  • User avatar
  • User avatar
  • User avatar
  • User avatar
#2352
2.drug interactions :digoxin and warfarin _loss of anticoagulant control .
this is a major pharmaceutical problem

3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids,
digoxin should be taken for only 5 days a week.
avoid chances of bleeding ,
using equipments for urinary tract should be a sterilised one .
#2354
1.The medication history, documented on the handwritten GP referral letter, included digoxin 0.625 mg daily, warfarin, furosemide 20 mg daily, gliclazide 80 mg twice daily, Tylex two tablets when required for pain, alendronate and Adcal-D3 plus ciprofloxacin 250 mg twice daily. An allergy to penicillin was also noted by the GP.
#2355
9.
step 1
Carry out a baseline assessment in a near patient
area (e.g., ward, clinic, home) in which injectables are prepared.

Step 2 – Product Risk Factor Assessment

Carry out a baseline assessment of individual
injectable products stocked and used in a near patient area.
step3:
identify risk reduction measures
step 4:
implement risk reduction strategies
#2356
1.The medication history, documented on the handwritten GP referral letter, included digoxin 0.625 mg daily, warfarin, furosemide 20 mg daily, gliclazide 80 mg twice daily, Tylex two tablets when required for pain, alendronate and Adcal-D3 plus ciprofloxacin 250 mg twice daily. An allergy to penicillin was also noted by the GP.
#2357
2.drug interactions :digoxin and warfarin _loss of anticoagulant control .
this is a major pharmaceutical problem

3.patient is dehydrated % also suffering from uti,so she should drink lots of fluids,
digoxin should be taken for only 5 days a week.
avoid chances of bleeding ,
using equipments for urinary tract should be a sterilised one .

In the dynamic world of pharmaceuticals, mergers a[…]

PharmD Info - Highlights